Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
19-21 November, 2024
Not Confirmed
Not Confirmed
19-21 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
19-21 November, 2024
Industry Trade Show
Not Confirmed
19-21 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/medical-breakthroughs-in-2024-alzheimer-s-schizophrenia-copd-mash-see-pathbreaking-treatments
14 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/14/2981036/0/en/Khondrion-receives-FDA-clearance-of-IND-application-for-pivotal-Phase-3-clinical-trial-of-sonlicromanol-for-the-treatment-of-primary-mitochondrial-disease.html
07 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/07/2976519/0/en/Khondrion-announces-publication-in-Brain-of-integrated-Phase-2b-program-demonstrating-disease-modifying-potential-of-sonlicromanol-in-primary-mitochondrial-disease.html
11 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/11/2944373/0/en/Khondrion-appoints-Jasper-Levink-as-Chief-Financial-and-Business-Officer.html
01 Nov 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/khondrion-announces-grant-of-patents-in-the-us-and-europe-for-its-lead-candidate-sonlicromanol-covering-the-anti-inflammatory-effect-on-mpges-1-301973246.html
22 Nov 2022
// Nick Paul Taylor FIERCEBIOTECH
https://www.fiercebiotech.com/biotech/clutching-post-hoc-analyses-khondrion-forges-despite-phase-2-mitochondrial-disease-fail
22 Nov 2022
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2022/11/22/2560649/0/en/Khondrion-announces-sonlicromanol-Phase-IIb-progress-supporting-Phase-III-development-in-MELAS-spectrum-disorders.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?